Ajanta Pharma standalone net profit declines 3.34% in the September 2018 quarter
Sales decline 0.82% to Rs 465.29 crore
Net profit of Ajanta Pharma declined 3.34% to Rs 104.10 crore in the quarter ended September 2018 as against Rs 107.70 crore during the previous quarter ended September 2017. Sales declined 0.82% to Rs 465.29 crore in the quarter ended September 2018 as against Rs 469.14 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales465.29469.14 -1 OPM %30.5133.56 -PBDT158.84165.32 -4 PBT141.98151.37 -6 NP104.10107.70 -3Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content